Generic placeholder image

Current Stem Cell Research & Therapy

Editor-in-Chief

ISSN (Print): 1574-888X
ISSN (Online): 2212-3946

Research Article

Intravenous Injection of SDF-1α-overexpressing Bone Marrow Mesenchymal Stem Cells has a Potential Protective Effect on Myocardial Ischemia in Mice

Author(s): Ruihua Wang, Wen Wei, Shuling Rong, Ting Wang and Bao Li*

Volume 17, Issue 4, 2022

Published on: 10 May, 2022

Page: [348 - 360] Pages: 13

DOI: 10.2174/1574888X17666220318144608

Price: $65

Abstract

Background: Neutrophils are involved in the injury of myocytes during myocardial ischemia (MI). Stem cells migrate to the site of myocardial injury under homing signals and play a protective role, such as inhibiting inflammation. Chemokine SDF-1α and its related receptor CXCR4 are upregulated after myocardial infarction, which may play an important role in stem cell homing.

Objectives: This study aimed to explore the potential therapeutic effect of SDF-1α-modified bone marrow mesenchymal stem cells on myocardial ischemia/reperfusion (I/R) injury.

Methods: We explored the role of SDF-1α modified bone marrow mesenchymal stem cells in vivo and in vitro. SDF-1α and CXCR4 expression was detected under hypoxia/reoxygenation (H/R) condition. Cell migration was detected by the transwell method. The levels of SDF-1α and IL-1β, IL-6, IL-10, and TNF-α were detected in different groups.

Results: In vitro, SDF-1α was mainly upregulated and secreted by cardiomyocytes, and cardiomyocytes recruited stem cells through the SDF-1/CXCR4 pathway to reduce the damage of polymorphic mononuclear neutrophils to cardiomyocytes under H/R. Upregulation of SDF-1α increased the migration ability of BMSC Stem Cells to H/R-induced cardiomyocytes. In vivo, intravenous injection of SDF-1α genemodified BMSC Stem Cells reduced inflammatory infiltration in the injured area as well as the level of systemic inflammatory factors.

Conclusion: SDF-1α-overexpressing BMSC Stem Cells protected the heart function of mice and significantly reduced I/R-induced myocardial injury, which has a potential protective effect on MI.

Keywords: Myocardial infarction, stromal cell-derived factor 1α, CXCR4, stem cells, homing, bone marrow.

Graphical Abstract

[1]
Oprescu N, Micheu MM, Scafa-Udriste A, Popa-Fotea NM, Dorobantu M. Inflammatory markers in acute myocardial infarction and the correlation with the severity of coronary heart disease. Ann Med 2021; 53(1): 1041-7.
[http://dx.doi.org/10.1080/07853890.2021.1916070] [PMID: 34180324]
[2]
Sun J, Zhao Y, Li Q, et al. Controlled release of collagen-binding SDF-1α improves cardiac function after myocardial infarction by recruiting endogenous stem cells. Sci Rep 2016; 6: 26683.
[http://dx.doi.org/10.1038/srep26683] [PMID: 27226084]
[3]
Saxena A, Fish JE, White MD, et al. Stromal cell-derived factor-1alpha is cardioprotective after myo-cardial infarction. Circulation 2008; 117(17): 2224-31.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.107.694992] [PMID: 18427137]
[4]
Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998; 393(6685): 595-9.
[http://dx.doi.org/10.1038/31269] [PMID: 9634238]
[5]
Carr AN, Howard BW, Yang HT, et al. Efficacy of systemic administration of SDF-1 in a model of vascular insufficiency: Support for an endothelium-dependent mechanism. Cardiovasc Res 2006; 69(4): 925-35.
[http://dx.doi.org/10.1016/j.cardiores.2005.12.005] [PMID: 16409996]
[6]
Petty JM, Lenox CC, Weiss DJ, Poynter ME, Suratt BT. Crosstalk between CXCR4/stromal derived factor-1 and VLA-4/VCAM-1 pathways regulates neutrophil retention in the bone marrow. J Immunol 2009; 182(1): 604-12.
[http://dx.doi.org/10.4049/jimmunol.182.1.604] [PMID: 19109194]
[7]
Akpek M, Kaya MG, Lam YY, et al. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Am J Cardiol 2012; 110(5): 621-7.
[http://dx.doi.org/10.1016/j.amjcard.2012.04.041] [PMID: 22608360]
[8]
Bae YK, Kim GH, Lee JC, et al. The significance of SDF-1α-CXCR4 Axis in in vivo angiogenic ability of human periodontal ligament stem cells. Mol Cells 2017; 40(6): 386-92.
[http://dx.doi.org/10.14348/molcells.2017.0004] [PMID: 28614918]
[9]
Hu X, Dai S, Wu WJ, et al. Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: Role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis. Circulation 2007; 116(6): 654-63.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.106.672451] [PMID: 17646584]
[10]
Maridas DE, Rendina-Ruedy E, Le PT, Rosen CJ. Isolation, culture, and differentiation of bone mar-row stromal cells and osteoclast progenitors from mice. J Vis Exp 2018; (131): 56750.
[http://dx.doi.org/10.3791/56750] [PMID: 29364278]
[11]
Swamydas M, Lionakis MS. Isolation, purification and labeling of mouse bone marrow neutrophils for functional studies and adoptive transfer experiments. J Vis Exp 2013; (77): e50586.
[http://dx.doi.org/10.3791/50586] [PMID: 23892876]
[12]
Gong XH, Liu H, Wang SJ, Liang SW, Wang GG. Exosomes derived from SDF1-overexpressing mesenchymal stem cells inhibit ischemic myocardial cell apoptosis and promote cardiac endothelial microvascular regeneration in mice with myocardial infarction. J Cell Physiol 2019; 234(8): 13878-93.
[http://dx.doi.org/10.1002/jcp.28070] [PMID: 30720220]
[13]
Huang FY, Xia TL, Li JL, et al. The bifunctional SDF-1-AnxA5 fusion protein protects cardiac func-tion after myocardial infarction. J Cell Mol Med 2019; 23(11): 7673-84.
[http://dx.doi.org/10.1111/jcmm.14640] [PMID: 31468674]
[14]
Cai X, Zhu Z, Zhang Y, Tian X. SDF-1α promotes repair of myocardial ischemic necrosis zones in rats. Int J Clin Exp Pathol 2019; 12(6): 1956-67.
[PMID: 31934018]
[15]
Kim BS, Jacobs D, Emontzpohl C, et al. Myocardial ischemia induces SDF-1α release in cardiac sur-gery patients. J Cardiovasc Transl Res 2016; 9(3): 230-8.
[http://dx.doi.org/10.1007/s12265-016-9689-x] [PMID: 27055858]
[16]
Ren J, Jin P, Sabatino M, et al. Global transcriptome analysis of human bone marrow stromal cells (BMSC) reveals proliferative, mobile and interactive cells that produce abundant extracellular matrix proteins, some of which may affect BMSC potency. Cytotherapy 2011; 13(6): 661-74.
[http://dx.doi.org/10.3109/14653249.2010.548379] [PMID: 21250865]
[17]
Abbuehl JP, Tatarova Z, Held W, Huelsken J. Long-term engraftment of primary bone marrow stro-mal cells repairs niche damage and improves hematopoietic stem cell transplantation. Cell Stem Cell 2017; 21(2): 241-255.e6.
[http://dx.doi.org/10.1016/j.stem.2017.07.004] [PMID: 28777945]
[18]
Ullah TR. The role of CXCR4 in multiple myeloma: Cells’ journey from bone marrow to beyond. J Bone Oncol 2019; 17: 100253.
[http://dx.doi.org/10.1016/j.jbo.2019.100253] [PMID: 31372333]
[19]
Yang Z, Sharma AK, Linden J, Kron IL, Laubach VE. CD4+ T lymphocytes mediate acute pulmo-nary ischemia-reperfusion injury. J Thorac Cardiovasc Surg 2009; 137(3): 695-702.
[http://dx.doi.org/10.1016/j.jtcvs.2008.10.044] [PMID: 19258091]
[20]
Ajuebor MN, Das AM, Virág L, Flower RJ, Szabó C, Perretti M. Role of resident peritoneal macro-phages and mast cells in chemokine production and neutrophil migration in acute inflammation: Evi-dence for an inhibitory loop involving endogenous IL-10. J Immunol 1999; 162(3): 1685-91.
[PMID: 9973430]
[21]
Hou F, Geng Q, Zhang F, Li Y. Protective effects of induced cardiosphere on myocardial ischemia-reperfusion injury through secreting interleukin 10. Int Immunopharmacol 2020; 80: 106207.
[http://dx.doi.org/10.1016/j.intimp.2020.106207] [PMID: 31958742]
[22]
Valent P, Akin C, Hartmann K, et al. Midostaurin: A magic bullet that blocks mast cell expansion and activation. Ann Oncol 2017; 28(10): 2367-76.
[http://dx.doi.org/10.1093/annonc/mdx290] [PMID: 28945834]
[23]
Espinosa G, Plaza A, Schenffeldt A, et al. Equine bone marrow-derived mesenchymal stromal cells inhibit reactive oxygen species production by neutrophils. Vet Immunol Immunopathol 2020; 221: 109975.
[http://dx.doi.org/10.1016/j.vetimm.2019.109975] [PMID: 32087476]
[24]
Abbasi A, Froushani SMA, Delirezh N, Mostafaei A. Caffeine alters the effects of bone marrow-derived mesenchymal stem cells on neutrophils. Adv Clin Exp Med 2018; 27(4): 463-8.
[http://dx.doi.org/10.17219/acem/78557] [PMID: 29943521]
[25]
Shologu N, Scully M, Laffey JG, O’Toole D. Human mesenchymal stem cell secretome from bone marrow or adipose-derived tissue sources for treatment of hypoxia-induced pulmonary epithelial inju-ry. Int J Mol Sci 2018; 19(10): 2996.
[http://dx.doi.org/10.3390/ijms19102996] [PMID: 30274394]
[26]
Lehwald N, Duhme C, Pinchuk I, et al. Platelets boost recruitment of CD133+ bone marrow stem cells to endothelium and the rodent liver-the role of P-Selectin/PSGL-1 interactions. Int J Mol Sci 2020; 21(17): 6431.
[http://dx.doi.org/10.3390/ijms21176431] [PMID: 32899390]
[27]
Yan XT, Cheng XL, He XH, Zheng WZ, Xiao-Fang Y, Hu C. The HO-1-expressing bone mesen-chymal stem cells protects intestine from ischemia and reperfusion injury. BMC Gastroenterol 2019; 19(1): 124.
[http://dx.doi.org/10.1186/s12876-019-1042-9] [PMID: 31299915]
[28]
Lu M, Xu Y, Wang M, et al. MicroRNA-23 inhibition protects the ischemia/reperfusion injury via in-ducing the differentiation of bone marrow mesenchymal stem cells into cardiomyocytes. Int J Clin Exp Pathol 2019; 12(3): 1060-9.
[PMID: 31933920]
[29]
Li X, Xie X, Yu Z, et al. Bone marrow mesenchymal stem cells-derived conditioned medium protects cardiomyocytes from hypoxia/reoxygenation-induced injury through Notch2/mTOR/autophagy signal-ing. J Cell Physiol 2019; 234(10): 18906-16.
[http://dx.doi.org/10.1002/jcp.28530] [PMID: 30953350]
[30]
Li X, Zhang Y, Wang Y, et al. Exosomes derived from CXCR4-overexpressing BMSC promoted ac-tivation of microvascular endothelial cells in cerebral ischemia/reperfusion injury. Neural Plast 2020; 2020: 8814239.
[http://dx.doi.org/10.1155/2020/8814239] [PMID: 33381162]
[31]
Kankuri E, Mervaala EE, Storvik M, et al. Exacerbation of acute kidney injury by bone marrow stro-mal cells from rats with persistent renin-angiotensin system activation. Clin Sci (Lond) 2015; 128(11): 735-47.
[http://dx.doi.org/10.1042/CS20140445] [PMID: 25534858]
[32]
Pan Q, Qin X, Ma S, et al. Myocardial protective effect of extracellular superoxide dismutase gene modified bone marrow mesenchymal stromal cells on infarcted mice hearts. Theranostics 2014; 4(5): 475-86.
[http://dx.doi.org/10.7150/thno.7729] [PMID: 24669277]
[33]
Kajiyama H, Shibata K, Ino K, Nawa A, Mizutani S, Kikkawa F. Possible involvement of SDF-1alpha/CXCR4-DPPIV axis in TGF-beta1-induced enhancement of migratory potential in human per-itoneal mesothelial cells. Cell Tissue Res 2007; 330(2): 221-9.
[http://dx.doi.org/10.1007/s00441-007-0455-x] [PMID: 17846797]
[34]
Németh K, Leelahavanichkul A, Yuen PS, et al. Bone marrow stromal cells attenuate sepsis via pros-taglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 produc-tion. Nat Med 2009; 15(1): 42-9.
[http://dx.doi.org/10.1038/nm.1905] [PMID: 19098906]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy